Riverhead Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $440K | Sell |
3,324
-2,292
| -41% | -$303K | 0.02% | 772 |
|
|
2019
Q2 | $797K | Buy |
5,616
+1,492
| +36% | +$212K | 0.03% | 566 |
|
|
2019
Q1 | $599K | Buy |
4,124
+900
| +28% | +$131K | 0.02% | 627 |
|
|
2018
Q4 | $365K | Sell |
3,224
-750
| -19% | -$84.9K | 0.02% | 789 |
|
|
2018
Q3 | $535K | Buy |
3,974
+500
| +14% | +$67.3K | 0.02% | 724 |
|
|
2018
Q2 | $390K | Sell |
3,474
-1,650
| -32% | -$185K | 0.02% | 772 |
|
|
2018
Q1 | $547K | Sell |
5,124
-100
| -2% | -$10.7K | 0.02% | 619 |
|
|
2017
Q4 | $572K | Buy |
5,224
+3,000
| +135% | +$328K | 0.02% | 607 |
|
|
2017
Q3 | $240K | Buy |
2,224
+293
| +15% | +$31.6K | 0.01% | 904 |
|
|
2017
Q2 | $195K | Buy |
1,931
+247
| +15% | +$24.9K | 0.01% | 938 |
|
|
2017
Q1 | $151K | Sell |
1,684
-116
| -6% | -$10.4K | 0.01% | 844 |
|
|
2016
Q4 | $137K | Buy |
1,800
+900
| +100% | +$68.5K | 0.01% | 849 |
|
|
2016
Q3 | $75K | Sell |
900
-13,224
| -94% | -$1.1M | ﹤0.01% | 1019 |
|
|
2016
Q2 | $116K | Buy |
14,124
+6,424
| +83% | +$52.8K | ﹤0.01% | 1119 |
|
|
2016
Q1 | $585K | Sell |
7,700
-1,100
| -13% | -$83.6K | 0.01% | 807 |
|
|
2015
Q4 | $707K | Buy |
8,800
+6,600
| +300% | +$530K | 0.01% | 728 |
|
|
2015
Q3 | $140K | Buy |
+2,200
| New | +$140K | ﹤0.01% | 891 |
|